XML 111 R39.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Revenue - Revenue Recognition (Details) | 3 Months Ended
--- | ---
Mar. 31, 2024 | Mar. 31, 2023
Revenue from Contract with Customer Benchmark | Customer Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 100.00% | 100.00%
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 100.00% | 100.00%
Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 100.00% | 100.00%
Americas | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 43.00% | 44.00%
Europe, Middle East, Africa | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 48.00% | 47.00%
Asia Pacific | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 9.00% | 9.00%
High-Value Product Components | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 47.00% | 51.00%
High-Value Product Delivery Devices | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 11.00% | 7.00%
Standard Packaging | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 22.00% | 23.00%
Contract-Manufactured Products | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 20.00% | 19.00%
Biologics | Revenue from Contract with Customer Benchmark | Customer Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 37.00% | 34.00%
Generics | Revenue from Contract with Customer Benchmark | Customer Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 18.00% | 20.00%
Pharma | Revenue from Contract with Customer Benchmark | Customer Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 25.00% | 27.00%
Contract-Manufactured Products | Revenue from Contract with Customer Benchmark | Customer Concentration Risk |  |
Disaggregation of Revenue [Line Items] |  |
Concentration risk, percentage | 20.00% | 19.00%

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AmericasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_HighValueProductComponentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_HighValueProductDeliveryDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_StandardPackagingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_BiologicsCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_GenericsCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_PharmaCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |